Teladoc Health Files 8-K on Financials
Ticker: TDOC · Form: 8-K · Filed: Oct 29, 2025 · CIK: 1477449
| Field | Detail |
|---|---|
| Company | Teladoc Health, Inc. (TDOC) |
| Form Type | 8-K |
| Filed Date | Oct 29, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: TDOC
TL;DR
TDOC filed an 8-K on Oct 29, 2025, reporting financial condition. Details to follow.
AI Summary
Teladoc Health, Inc. filed an 8-K on October 29, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a formal reporting event.
Why It Matters
This filing signals that Teladoc Health is providing updated financial information and operational details to the SEC, which is crucial for investors to assess the company's performance and outlook.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting financial condition and does not, in itself, indicate any immediate or significant risks.
Key Players & Entities
- Teladoc Health, Inc. (company) — Registrant
- October 29, 2025 (date) — Date of Report
- 155 E 44th Street Suite 1700 New York, NY 10017 (address) — Principal executive offices
- 001-37477 (filing_id) — SEC File Number
FAQ
What specific financial results or conditions are being reported by Teladoc Health, Inc. in this 8-K?
The provided text of the 8-K filing indicates that it pertains to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but it does not contain the specific financial figures or details of these results.
When was this 8-K report filed with the SEC?
This 8-K report was filed with the SEC on October 29, 2025.
What is the primary purpose of this 8-K filing for Teladoc Health, Inc.?
The primary purpose of this 8-K filing is to report on Teladoc Health, Inc.'s results of operations and financial condition, along with providing financial statements and exhibits.
What is the principal executive office address for Teladoc Health, Inc. as listed in this filing?
The principal executive offices of Teladoc Health, Inc. are located at 155 E 44th Street, Suite 1700, New York, NY 10017.
Does this filing mention any significant changes in the company's business or management?
The provided excerpt of the 8-K filing focuses on the reporting of financial condition and does not include information about changes in business or management.
Filing Stats: 503 words · 2 min read · ~2 pages · Grade level 9.7 · Accepted 2025-10-29 16:04:53
Key Financial Figures
- $0.001 — ch registered Common stock, par value $0.001 per share TDOC The New York Stock Excha
Filing Documents
- tdoc-20251029.htm (8-K) — 26KB
- tdoc-20250930xexx991.htm (EX-99.1) — 375KB
- image_0a.jpg (GRAPHIC) — 6KB
- 0001477449-25-000117.txt ( ) — 553KB
- tdoc-20251029.xsd (EX-101.SCH) — 2KB
- tdoc-20251029_lab.xml (EX-101.LAB) — 22KB
- tdoc-20251029_pre.xml (EX-101.PRE) — 13KB
- tdoc-20251029_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On October 29, 2025, Teladoc Health, Inc. (the "Company") issued a press release relating to its financial results for the third quarter of 2025. A copy of the press release, which is incorporated by reference herein, is attached hereto as Exhibit 99.1. The foregoing information (including the exhibit set forth in Item 9.01 hereto) is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1* Teladoc Health, Inc. press release, dated October 29, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). * Furnished herewith. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 29, 2025 Teladoc Health, Inc. By: /s/ Adam C. Vandervoort Name: Adam C. Vandervoort Title: Chief Legal Officer and Secretary